These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Selective estrogen receptor modulators (SERM): new substances for hormone replacement therapy]. Burckhardt P Schweiz Med Wochenschr; 1999 Dec; 129(49):1926-30. PubMed ID: 10635085 [TBL] [Abstract][Full Text] [Related]
45. Selective estrogen receptor modulators and phytoestrogens: new therapies for the postmenopausal women. Fitzpatrick LA Mayo Clin Proc; 1999 Jun; 74(6):601-7. PubMed ID: 10377937 [TBL] [Abstract][Full Text] [Related]
46. [The role of phytoestrogen therapy in relieving postmenopausal symptoms]. Szkutnik-Fiedler D; Jedrzejczyk M; Grześkowiak E; Bartkowiak-Wieczorek J; Seremak-Mrozikiewicz A; Drews K; Mrozikiewicz PM Ginekol Pol; 2010 Dec; 81(12):929-34. PubMed ID: 21395085 [TBL] [Abstract][Full Text] [Related]
48. Phytoestrogens and the management of menopause. Ramsey LA; Ross BS; Fischer RG Adv Nurse Pract; 1999 May; 7(5):26-30. PubMed ID: 10578731 [TBL] [Abstract][Full Text] [Related]
49. The pros and cons of plant estrogens for menopause. Bedell S; Nachtigall M; Naftolin F J Steroid Biochem Mol Biol; 2014 Jan; 139():225-36. PubMed ID: 23270754 [TBL] [Abstract][Full Text] [Related]
50. Managing menopausal problems. Cobleigh MA Cancer Treat Res; 2000; 103():1-23. PubMed ID: 10948439 [No Abstract] [Full Text] [Related]
51. Comparative cardiovascular effects of different progestins in menopause. Rosano GM; Fini M Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197 [TBL] [Abstract][Full Text] [Related]
52. Phytoestrogens and the menopause. Eden J Baillieres Clin Endocrinol Metab; 1998 Dec; 12(4):581-7. PubMed ID: 10384814 [TBL] [Abstract][Full Text] [Related]
53. Use of SERMs for treatment in postmenopausal women. Pinkerton JV; Thomas S J Steroid Biochem Mol Biol; 2014 Jul; 142():142-54. PubMed ID: 24373794 [TBL] [Abstract][Full Text] [Related]
54. Hormones, herbal preparations and nutriceuticals for a better life after the menopause: part I. Comhaire FH; Depypere HT Climacteric; 2015 Jun; 18(3):358-63. PubMed ID: 25668235 [TBL] [Abstract][Full Text] [Related]
56. Emerging selective estrogen receptor modulators: special focus on effects on coronary heart disease in postmenopausal women. Vogelvang TE; van der Mooren MJ; Mijatovic V; Kenemans P Drugs; 2006; 66(2):191-221. PubMed ID: 16451093 [TBL] [Abstract][Full Text] [Related]
57. Medical choices available for management of menopause. Farrell E Best Pract Res Clin Endocrinol Metab; 2003 Mar; 17(1):1-16. PubMed ID: 12763509 [TBL] [Abstract][Full Text] [Related]
59. Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone. Lippuner K; Haenggi W; Birkhaeuser MH; Casez JP; Jaeger P J Bone Miner Res; 1997 May; 12(5):806-12. PubMed ID: 9144347 [TBL] [Abstract][Full Text] [Related]
60. A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Glazier MG; Bowman MA Arch Intern Med; 2001 May; 161(9):1161-72. PubMed ID: 11343439 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]